Rubicon Organics Inc. (ROMJ.V)
CAD 0.4
(-1.25%)
CAD 0.4
(-1.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 54.89 Million CAD | -2.17% |
| 2022 | 56.1 Million CAD | 2.31% |
| 2021 | 54.84 Million CAD | 7.38% |
| 2020 | 51.07 Million CAD | 28.4% |
| 2019 | 39.77 Million CAD | 40.41% |
| 2018 | 28.32 Million CAD | 29.25% |
| 2017 | 21.91 Million CAD | 67.52% |
| 2016 | 13.08 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 55.88 Million CAD | 4.45% |
| 2024 Q1 | 53.5 Million CAD | -2.53% |
| 2023 Q3 | 54.37 Million CAD | -3.07% |
| 2023 Q4 | 54.89 Million CAD | 0.94% |
| 2023 FY | 54.89 Million CAD | -2.17% |
| 2023 Q2 | 56.09 Million CAD | 3.19% |
| 2023 Q1 | 54.36 Million CAD | -3.11% |
| 2022 Q2 | 53.91 Million CAD | 0.71% |
| 2022 Q1 | 53.53 Million CAD | -2.37% |
| 2022 Q4 | 56.1 Million CAD | -2.37% |
| 2022 Q3 | 57.46 Million CAD | 6.58% |
| 2022 FY | 56.1 Million CAD | 2.31% |
| 2021 FY | 54.84 Million CAD | 7.38% |
| 2021 Q4 | 54.84 Million CAD | -1.65% |
| 2021 Q3 | 55.76 Million CAD | -1.85% |
| 2021 Q2 | 56.81 Million CAD | -9.35% |
| 2021 Q1 | 62.67 Million CAD | 22.72% |
| 2020 Q4 | 51.07 Million CAD | 14.5% |
| 2020 Q3 | 44.6 Million CAD | -2.86% |
| 2020 Q2 | 45.91 Million CAD | 8.19% |
| 2020 FY | 51.07 Million CAD | 28.4% |
| 2020 Q1 | 42.44 Million CAD | 6.7% |
| 2019 Q1 | 30.18 Million CAD | 6.57% |
| 2019 FY | 39.77 Million CAD | 40.41% |
| 2019 Q4 | 39.77 Million CAD | 2.39% |
| 2019 Q3 | 38.84 Million CAD | 15.86% |
| 2019 Q2 | 33.52 Million CAD | 11.06% |
| 2018 Q4 | 28.32 Million CAD | -9.06% |
| 2018 FY | 28.32 Million CAD | 29.25% |
| 2018 Q3 | 31.15 Million CAD | 0.0% |
| 2017 FY | 21.91 Million CAD | 67.52% |
| 2017 Q4 | 21.91 Million CAD | 0.0% |
| 2016 FY | 13.08 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -4953.386% |
| CanadaBis Capital Inc. | 22.96 Million CAD | -139.041% |
| Decibel Cannabis Company Inc. | 142.98 Million CAD | 61.611% |
| Delivra Health Brands Inc. | 10.05 Million CAD | -446.071% |
| Entourage Health Corp. | 31.39 Million CAD | -74.853% |
| Lifeist Wellness Inc. | 13.39 Million CAD | -309.661% |
| Cannara Biotech Inc. | 141.52 Million CAD | 61.214% |
| Medicure Inc. | 28.05 Million CAD | -95.627% |
| PharmaCielo Ltd. | 22.28 Million CAD | -146.265% |
| BioSyent Inc. | 41.52 Million CAD | -32.175% |
| Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -2436.951% |